Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2014 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Chemical metabolic inhibitors for the treatment of blood-borne cancers.
Villalba M, Lopez-Royuela N, Krzywinska E, Rathore MG, Hipskind RA, Haouas H, Allende-Vega N. Villalba M, et al. Anticancer Agents Med Chem. 2014 Feb;14(2):223-32. doi: 10.2174/18715206113136660374. Anticancer Agents Med Chem. 2014. PMID: 24237221 Free PMC article. Review.
This process is called "the Warburg effect" and offers an attractive pharmacological target to preferentially eliminate malignant cells. In addition, recent results show that metabolic changes can be linked to tumor immune evasion. Mouse models demonstrate the importance o …
This process is called "the Warburg effect" and offers an attractive pharmacological target to preferentially eliminate malignant cells. In …
Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
Naggi A, Casu B, Perez M, Torri G, Cassinelli G, Penco S, Pisano C, Giannini G, Ishai-Michaeli R, Vlodavsky I. Naggi A, et al. J Biol Chem. 2005 Apr 1;280(13):12103-13. doi: 10.1074/jbc.M414217200. Epub 2005 Jan 12. J Biol Chem. 2005. PMID: 15647251 Free article.
Heparanase is an endo-beta-glucuronidase that cleaves heparan sulfate (HS) chains of heparan sulfate proteoglycans on cell surfaces and in the extracellular matrix (ECM). Heparanase, overexpressed by most cancer cells, facilitates extravasation of blood-borne
Heparanase is an endo-beta-glucuronidase that cleaves heparan sulfate (HS) chains of heparan sulfate proteoglycans on cell surfaces and in t …